Following Pivotal $21.3 Million Investment, higi Announces Dr. Chris Kryder as New Executive Chairman

Established healthcare innovator will further company's applications connecting consumers and their data with healthcare stakeholders CHICAGO – July 31, 2018 – On the heels of announcing $21.3 Million in Series C investment, Chicago-based higi, an industry leader and innovator in population health enablement, today announced Dr. Chris Kryder as its new executive chairman.Dr. Kryder is a proven executive in the healthcare information technology arena with decades of experience successfully leading and growing healthcare IT companies. He joins a highly qualified and experienced board of directors that includes Dr. Robert Wah, former president of the American Medical Association, and Peter Neupert, former General Manager of Microsoft Health and CEO of Drugstore.com.Dr. Kryder takes on the role as executive chairman following the company’s latest fundraising round of $21.3 million from existing and new investors including Boston-based Flare Capital Partners, where Dr. Kryder is an executive partner, and Chicago-based 7wireVentures.  With this latest investment, Dr. Kryder and the board will focus on accelerating the development of higi’s applications that connect consumers and their data directly into the workflow of at-risk healthcare organizations.“It’s a terrific time to be in healthcare services, as technology - particularly remote diagnostics and monitoring - is improving the delivery of patient care, and as retail organizations are opening a new front door. higi’s machines meet consumers where they shop, and transmit data securely into the workflow of their doctors. This is likely to be a significant part of the future of healthcare, and I’m proud, as higi moves into high growth phase, to be part of it,” said Dr. Kryder. Most recently, Dr. Kryder served as Chairman of Valence Health from 2012-2016, which merged with EvolentHealth (NASDAQ: EVH) in 2016. He was the Founder and CEO of the analytics vendor D2Hawkeye, and then CEO of Verisk Health after Verisk’s IPO (NASDAQ: VRSK) in 2009. Dr. Kryder also co-founded Generation Health, the first genetic testing benefits manager, which sold to CVS Caremark in 2010.In addition to his business accomplishments, Dr. Kryder maintains his medical license in Massachusetts. He was formerly a primary care internist at the Medical Department at the Massachusetts Institute of Technology, where he also managed clinical operations. He was also active on the faculty of Harvard Medical School, Division of Health, Science, and Technology for more than 25 years. Massachusetts Governor Baker recently named Dr. Kryder as the physician representative on the Massachusetts Health Policy Commission.Engaging consumers in their health since 2012, higi has been used by an estimated 50 million people, conducting over 285 million biometric tests creating the foundation for deep knowledge about consumer engagement and the translation of the health narrative to prevention, early intervention and real-time care team adjustments.  Find out more about higi here.ABOUT HIGI:higi is a population health enablement company that empowers consumers to measure, track and act on their health data. Through a nationwide network of over 11,000 FDA-cleared self-screening stations found at pharmacy retailers and other community locations and over 80 different third-party integrations, higi makes it easier to engage consumers in their health. As the largest repository of standardized biometric data, higi’s population health solutions enable healthcare organizations to better reach targeted populations; collect biometric and other health determinant data to stratify and prioritize consumers; and motivate consumers to take specific actions at a point of care. To date, more than 50 million people have used a higi health station to conduct over 285 million biometric tests. For more information, visit us at www.higi.com.###